Latest Cellular and molecular biology biotechnology articles and news on biotech industry leaders, emerging biotech companies in Spain

The Bigas Lab finds Notch self-inhibition keeps haematopoietic stem cells from differentiate

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

2 months ago
NOTCH, haematopoietic stem cells (HSC), JAGGED1, FRINGE, regenerative medicine

It has been found that the population of haematopoietic stem cells (HSC) responsible for the generation and self-renewal of the blood and immune system keeps a long-term undifferentiated state thanks ...

How do we age?

by Universitat Politècnica de València

2 months ago
senescent cells

A new probe helps to understand the ageing process better and develop new strategies to reverse the degenerative processes associated with ageing.

Modular portable laboratories for biocontainment activities

by Albian Group

2 months ago
modular portable laboratories (MPL)

At Albian Group they are specialists in the construction of controlled environment facilities, also offering small format clean room solutions. This is possible thanks to their modular portable labora...

CIC bioGUNE presents the new Nuclear Magnetic Resonance (NMR) facilities

by CIC bioGUNE

2 months ago
1 GHz, Nuclear Magnetic Resonance (NMR)

With this latest acquisition of 1 GHz equipment, the CIC bioGUNE NMR facilities are now among the most advanced in southern Europe, highlighting the capacity of the research centre to lead research in...

Identificados potenciales biomarcadores asociados a la respuesta a fármacos epigenéticos en pacientes con síndrome mielodisplásico

by Revista Genética Médica

Han utilizado un novedoso enfoque multiómico para caracterizar las células de la médula ósea de pacientes con síndrome mielodisplásico tratados con agentes hipometilantes, con el objetivo de ide...

ORYZON reports financial results and corporate update for quarter ended December 31, 2023

by Oryzon Genomics

2 months ago
Oryzon Genomics

yzon Genomics, a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with a strong unmet medical need, today reported financial results for the fourth quar...

A new model for understanding the brain and its interaction with the environment paves the way for more accurate diagnoses and treatments

by UPF - Universitat Pompeu Fabra

2 months ago
synergistic model

As its name suggests, the synergistic framework is characterized by looking for the dynamics of different levels of brain functioning. Their combination gives rise to a new, more accurate and richer f...

New, more biocompatible materials for bioelectronic applications

by CIC biomaGUNE

2 months ago
e-Prot, PEDOT:PSS, PEDOT:CTPR3, bioelectronic

The proposal is to combine a conventional conductive polymer with engineered proteins so that new materials with bioelectronic applications can be synthesized

Capturando los orígenes de la metástasis de cáncer de mama en los huesos

by Biodonostia

2 months ago
cáncer de mama, metástasis

El grupo de investigación Bioingeniería en Regeneración y Cáncer del Instituto de Investigación Sanitaria Biogipuzkoa, dirigido por la Dra. Amaia Cipitria e investigadora IKERBASQUE, ha publicado...

Younes Smani colidera una Red Europea para el Diagnóstico y el Tratamiento de las Infecciones por Bacterias Resistentes a los Antibióticos

by Universidad Pablo de Olavide, de Sevilla

2 months ago
Red EURESTOP

El profesor del Área de Microbiología de la Universidad Pablo de Olavide, que desarrolla su trabajo en el Centro Andaluz de Biología del Desarrollo, dirige uno de los tres grupos de trabajo de la R...

Learning and Memory Problems in Down syndrome Linked to Alterations in Genome's ‘Dark Matter’

by Centre for Genomic Regulation

2 months ago
Snhg11 gene, Down syndrome, hippocampus

Researchers at the Centre for Genomic Regulation (CRG) reveal that the Snhg11 gene is critical for the function and formation of neurons in the hippocampus. Experiments with mice and human tissues rev...

ARTHEx Biotech, backed by Columbus Venture Partners, receives IND Clearance from FDA to Initiate the Phase I-IIa ArthemiR™ Trial of ATX-01 for Myotonic Dystrophy Type 1 (DM1)

by ARTHEx Biotech

2 months ago
Myotonic Dystrophy Type 1 (DM1)., ATX-01, ArthemiRTM, MBNL proteins, ARTHEx Biotech, Columbus Venture Partners

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs backed by Columbus Venture Partners, has announced that the ...